Experts In Residence

M2D2’s new Experts-in-Residence (EIR) Program brings seasoned industry professionals directly to our Lowell space to meet with startups. These drop-in sessions give founders practical guidance on everything from regulatory strategy and IP to fundraising, accounting, prototyping, and go-to-market planning. Sessions are held in-person on the third floor at 110 Canal

Tuesday, October 28th, 10:00 AM–1:00 PM

Featuring: Kristofer Munroe, MedTech Market Access & Reimbursement Expert

Kristofer Munroe is an experienced MedTech market access professional and patient advocate specializing in reimbursement, health economics, compliance, and access to care.

As Director of Compliance, Reimbursement, Health Economics & Market Access at PRIA Healthcare, Kristofer works with medical technology companies to navigate the path from product development to patient access.

Kristofer can provide guidance on:

• Market access and reimbursement strategy
• Payer strategy and engagement
• Coding and coverage considerations
• Health economics and outcomes research (HEOR)
• Developing clinical and economic value propositions
• KOL and payer influencer strategy
• Patient access and reimbursement support
• Preparing for commercialization and product launch

His experience spans early-stage startups through large-scale commercial launches, making him a valuable resource for innovators at different stages of the MedTech commercialization journey.

Thursday, November 12, 10:00 AM–1:00 PM

Featuring: Sam Murray, MedTech Regulatory & Quality Expert

Sam Murray brings more than a decade of experience helping medical technology companies navigate regulatory requirements and quality challenges.

As Head of Regulatory & Quality at PRIA Healthcare, Sam guides companies on regulatory strategy, global product approvals, and quality system development throughout the product lifecycle.

Sam can provide guidance on:

• U.S. regulatory strategy and FDA submission planning
• Global regulatory submissions, including European MDR and IVDR
• Quality system development and improvement
• Design controls and risk management
• Regulatory authority engagement
• Regulatory and quality considerations for commercialization

A former FDA medical device investigator, Sam combines regulatory insight with industry leadership experience to help innovators make informed decisions from early development through commercialization.